Clinical trial
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in…
NCT00268151 · University of Louisville, Other · Terminated
Key facts
| NCT number | NCT00268151 |
|---|---|
| Title | Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer |
| Official title | Phase I Study of Oxaliplatin (Eloxatin) and Capecitabine (Xeloda) and Concurrent Radiation Therapy (XELOX-RT) in Non-Small Cell Lung Cancer |
| Lead sponsor | University of Louisville, Other |
| Collaborators | James Graham Brown Cancer Center Sanofi Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-Small Cell Lung |
| Intervention type | Drug |
| Interventions | Oxaliplatin, Capecitabine |
| Enrollment | 24 |
| Start date | Feb 1, 2005 |
| Primary completion | Feb 1, 2007 |
| First posted | Dec 22, 2005 |
| Last update posted | Mar 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: